ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,842Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 783

$1.45M Total Retail Price of All Prescriptions

Rank: 11 out of 783

716 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 716 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 716 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 22,821 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LISINOPRIL 1,019 858 1 4
OMEPRAZOLE 999 721 2 6
SIMVASTATIN 929 742 3 3
LEVOTHYROXINE SODIUM 881 772 4 1
FUROSEMIDE 844 750 5 7
DONEPEZIL HCL 791 748 6 24
WARFARIN SODIUM 648 472 7 10
NAMENDA 646 592 8 32
HYDROCODONE-ACETAMINOPHEN 615 506 S3 9 2
METOPROLOL TARTRATE 593 520 10 9
POTASSIUM CHLORIDE 584 483 11 16
PRAVASTATIN SODIUM 559 456 12 14
AMLODIPINE BESYLATE 542 454 13 5
HYDROCHLOROTHIAZIDE 481 410 14 12
METFORMIN HCL 463 341 15 8
SERTRALINE HCL 354 309 16 22
ALENDRONATE SODIUM 333 250 17 25
CEPHALEXIN 311 277 18 70
GABAPENTIN 307 236 19 15
GLIPIZIDE 297 243 20 71
TRAMADOL HCL 279 266 21 20
DIVALPROEX SODIUM 275 246 22 72
GEMFIBROZIL 260 202 23 105
MIRTAZAPINE 242 235 24 52
ESCITALOPRAM OXALATE 241 226 25 54
POLYETHYLENE GLYCOL 3350 231 156 26 43
RISPERIDONE 227 186 27 67
PANTOPRAZOLE SODIUM 221 193 28 30
EXELON 220 218 29 109
LANTUS 215 170 30 38
LEVOFLOXACIN 211 189 31 75
TAMSULOSIN HCL 210 173 32 26
QUETIAPINE FUMARATE 199 162 33 79
RANITIDINE HCL 190 141 34 44
ATORVASTATIN CALCIUM 189 170 35 11
CARVEDILOL 183 143 36 21
CIPROFLOXACIN HCL 178 144 37 62
NYSTATIN 177 160 38 106
METOPROLOL SUCCINATE 162 140 39 13
CLOPIDOGREL 161 151 40 29
CITALOPRAM HBR 159 140 41 19
NOVOLIN R 153 114 42 185
TRIAMCINOLONE ACETONIDE 150 135 43 151
ATENOLOL 148 131 44 17
NIFEDIPINE ER 147 147 45 135
DIGOXIN 146 140 46 61
OLANZAPINE 143 116 47 108
LOVASTATIN 140 129 48 58
CYMBALTA 139 120 49 35
LEVETIRACETAM 137 78 50 89
ISOSORBIDE MONONITRATE ER 136 121 51 40
IPRATROPIUM-ALBUTEROL 134 123 52 110
PAROXETINE HCL 132 77 53 69
LOSARTAN POTASSIUM 131 116 54 18
PLAVIX 126 116 55 51
CARBIDOPA-LEVODOPA 126 113 55 88
DOXYCYCLINE HYCLATE 117 89 57 112
DILTIAZEM 24HR CD 112 87 58 118
AMOXICILLIN 106 89 59 116
AGGRENOX 102 90 60 196
HUMULIN 70-30 102 59 60 211
PROAIR HFA 102 83 60 56
NOVOLIN 70-30 99 72 63 227
MUPIROCIN 98 81 64 203
NITROGLYCERIN PATCH 95 95 65 187
RAMIPRIL 93 93 66 113
FAMOTIDINE 91 81 67 55
OXYBUTYNIN CHLORIDE 89 82 68 96
PREDNISONE 88 87 69 36
LAMOTRIGINE 86 65 70 156
FLUOXETINE HCL 85 69 71 45
HUMALOG 85 68 71 101
AZITHROMYCIN 85 69 71 41
NOVOLOG 82 74 74 81
DILTIAZEM ER 82 71 74 153
DILTIAZEM 24HR ER 81 66 76 122
ADVAIR DISKUS 81 64 76 50
ACTONEL 80 49 78 224
ALLOPURINOL 79 79 79 31
HUMULIN R 79 72 79 284
CLOTRIMAZOLE-BETAMETHASONE 78 56 81 189
PHENYTOIN SODIUM EXTENDED 76 27 82 141
OXYCODONE-ACETAMINOPHEN 76 40 S2 82 76
ZETIA 75 65 84 80
TRAZODONE HCL 75 65 84 39
SPIRONOLACTONE 74 59 86 57
LYRICA 74 30 86 98
ZOLPIDEM TARTRATE 73 45 88 23
LOPERAMIDE 73 65 88 244
FENTANYL 73 61 S2 88 65
BENZTROPINE MESYLATE 71 50 R 91 198
SPIRIVA 69 59 92 59
KLOR-CON M20 68 68 93 48
METOCLOPRAMIDE HCL 68 38 93 121
GLUCAGEN 67 60 95 285
CLONIDINE HCL 65 64 96 60
BACLOFEN 64 28 97 125
NEXIUM 63 39 98 28
JANUVIA 60 53 99 73
LEXAPRO 60 57 99 181
AMITRIPTYLINE HCL 59 45 R 101 77
BRIMONIDINE TARTRATE 59 52 101 299
SEROQUEL 59 43 101 183
INSULIN SYRINGE 59 38 101 82
CARBAMAZEPINE 57 12 105 208
GLYBURIDE 57 47 R 105 111
FLUTICASONE PROPIONATE 57 27 105 46
SOTALOL 56 56 108 305
VERAPAMIL ER 55 55 109 119
HALOPERIDOL 55 24 109 216
ROPINIROLE HCL 55 48 109 74
DILTIAZEM HCL 54 48 112 207
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 31 112 33
CYCLOBENZAPRINE HCL 53 27 R 114 63
CILOSTAZOL 52 52 115 232
VENLAFAXINE HCL ER 52 52 115 100
HYDROCORTISONE 52 30 115 302
HYDRALAZINE HCL 51 34 118 78
GLIMEPIRIDE 50 50 119 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 6, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.